S

everal items in a draft version of a White House executive order on drug pricing are causing consternation, but some Democratic lawmakers are especially upset the Trump administration seeks to weaken a program that offers discounts on medicines to hospitals.

The 340B Drug Discount Program, as it is known, requires drug makers to offer discounts of up to 50 percent on all outpatient drugs — for everything from AIDS to diabetes — to hospitals and clinics that serve indigent populations.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.

X